Get the Stockscreener App
3.38
6.63%
-0.24
Pre-market:
3.48
0.10
+2.96%
Lifemd Inc stock is traded at $3.38, with a volume of 1.07M.
It is down -6.63% in the last 24 hours and down -27.16% over the past month.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
See More
Previous Close:
$3.62
Open:
$3.62
24h Volume:
1.07M
Relative Volume:
1.05
Market Cap:
$163.47M
Revenue:
$219.42M
Net Income/Loss:
$-15.09M
P/E Ratio:
-8.127
EPS:
-0.4159
Net Cash Flow:
$-3.05M
1W Performance:
-13.33%
1M Performance:
-27.16%
6M Performance:
+16.15%
1Y Performance:
-49.70%
1-Day Range:
$3.355
$3.71
1-Week Range:
$3.00
$4.02
52-Week Range:
$2.56
$7.32
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
3.38 | 187.16M | 219.42M | -15.09M | -3.05M | -0.4159 |
VEEV
Veeva Systems Inc
|
236.58 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
57.89 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
55.69 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
105.57 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
58.48 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-16-26 | Upgrade | Mizuho | Neutral → Outperform |
| Jun-18-25 | Reiterated | BTIG Research | Buy |
| Dec-10-24 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-23-24 | Resumed | B. Riley Securities | Buy |
| Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-30-23 | Initiated | Craig Hallum | Buy |
| Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-03-23 | Initiated | H.C. Wainwright | Buy |
| Mar-10-22 | Initiated | Colliers Securities | Buy |
| Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
LifeMD, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:LFMD) 2026-08-11 - Seeking Alpha
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Cuts Target Price to $9 - Moomoo
Renaissance Technologies LLC Trims Stock Holdings in LifeMD, Inc. $LFMD - MarketBeat
LifeMD Inc (LFMD) Stock News Today - TradingKey
LifeMD, Inc. (LFMD) stock price, news, quote and history - Yahoo Finance Singapore
LFMD Maintains Buy Rating by HC Wainwright & Co. -- Price Target Lowered to $9.00 - GuruFocus
LifeMD (NASDAQ:LFMD) Price Target Lowered to $9.00 at HC Wainwright - MarketBeat
LFMD Maintained by B. Riley Securities -- Price Target Lowered t - GuruFocus
LifeMD, Inc. Stock 12‑Month Price Target Cut to $9, Implies 145% Upside - TradingView
LifeMD (NASDAQ:LFMD) Price Target Cut to $8.00 by Analysts at B. Riley Financial - MarketBeat
B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating - Moomoo
LifeMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
LFMD Maintained by BTIG -- Price Target Lowered to $9.00 - GuruFocus
BTIG Research Lowers LifeMD (NASDAQ:LFMD) Price Target to $9.00 - MarketBeat
(LFMDP) Risk Channels and Responsive Allocation - Stock Traders Daily
LFMD Looks 36.9% Undervalued on GF Value™ Despite Revenue Foreca - GuruFocus
LFMD Looks 36.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
LifeMD earnings missed by $0.06, revenue fell short of estimates - Investing.com South Africa
LifeMD (NASDAQ:LFMD) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
LifeMD Inc reports results for the quarter ended June 30Earnings Summary - TradingView
LifeMD Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: LifeMD posts Q2 revenue miss, shares sink in after-hours - Investing.com
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
UPDATELifeMD Reports Second Quarter 2026 Results - The Manila Times
Is LifeMD Inc (LFMD) Undervalued After Q2 Earnings Miss? EPS of - GuruFocus
LifeMD August 2026 slides: growth vision meets Q2 execution gap - Investing.com
LifeMD Q2 2026 slides tout AI platform, results miss targets - Investing.com
LifeMD, Inc. Q2 2026: Revenue $47.28M, EPS $(0.16) — 10-Q Summary - TradingView
LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs - TradingView
LifeMD (NASDAQ: LFMD) posts $15.96M loss but holds $25.1M cash and $30M credit line - Stock Titan
LIFEMD REPORTS SECOND QUARTER 2026 RESULTS - Moomoo
LifeMD, Inc. Provides Earnings Guidance for the Third Quarter and Fourth Quarter of 2026 - marketscreener.com
LifeMD Q2 2026 slides tout AI platform, results miss targets By Investing.com - Investing.com Nigeria
Earnings To Watch: LifeMD Inc (LFMD) Q2 2026 -- GF Value Sees 92% Upside - Yahoo Finance
LFMD Q2'26 Earnings: revenue estimate is 49.16M USD - TradingView
LifeMD (LFMD) Projected to Announce Quarterly Earnings on Wednesday - MarketBeat
LifeMD Inc (LFMD) Institutional Confidence - TradingKey
LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LFMD|LifeMD Inc|Price:3.875|Chg%:+0.165 - TradingKey
LifeMD Inc (LFMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LifeMD Inc (LFMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LifeMD Inc (LFMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LifeMD Inc (LFMD) Balance Sheet - TradingKey
LifeMD Inc (LFMD) Earnings Date & Reports & Earnings News - TradingKey
LifeMD Inc (LFMD) Income Statement - TradingKey
LFMD|LifeMD Inc|Price:3.735|Chg%:+0.235 - TradingKey
LFMD|LifeMD Inc|Price:3.710|Chg%:-0.160 - TradingKey
Lifemd, Inc. (LFMD) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Lifemd, Inc. (LFMD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
LifeMD to Report Second Quarter 2026 Financial Results on August 5 - The Manila Times
LifeMD schedules Aug. 5 update after U.S. markets close - Stock Titan
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifemd Inc Stock (LFMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
0.65%
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):